Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Journal of Inherited Metabolic Disease|July 11, 2025
Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis DefectsYasmin Polak, Elles Marleen Kemper, Marc Engelen, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2020
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation studyL H Mammatas, A S Zandvliet, M Rovithi, et al.
Bioanalysis|September 30, 2015
An UPLC-MS detection method for the quantification of five antibiotics in human plasmaAbdel Chahbouni, Frank Am van den Dungen, René M Vos, et al.
Journal of Inherited Metabolic Disease|March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous XanthomatosisNatalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
European Journal of Haematology|April 4, 2020
Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burdenChristel C L M Boons, Yvonne M den Hartog, Jeroen J W M Janssen, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2015
Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancerLonneke Timmers, Christel C L M Boons, J Moes-Ten Hove, et al.
Critical Care (London, England)|May 24, 2019
Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional studyLucas M Fleuren, Luca F Roggeveen, Tingjie Guo, et al.
The Journal of Pharmacy and Pharmacology|June 24, 2017
Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood samplingChristel C L M Boons, Abdel Chahbouni, Anneliene M Schimmel, et al.
British Journal of Clinical Pharmacology|February 21, 2017
An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamineAnne Catrien Baakman, Ricardo Alvarez-Jimenez, Robert Rissmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2025
Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic AnalysisMedhat M Said, Job R Schippers, Leila Atmowihardjo, et al.
Pageof 12